Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: In vitro and in vivo evaluation of the radiosensitizing effect of a selective FGFR inhibitor (JNJ-42756493) for rectal cancer

Fig. 4

Anti-tumor activity in vivo. Growth curves of mice bearing NCI-H716 (a) and Caco2 (b) xenograft tumors (▪). Control tumor-bearing animals received vehicle (▴). Relative tumor volumes (RTV) are shown. The line under the graph represents the period of treatment. All data points are mean ± STDEV of at least 10 tumors per treatment group. NCI-H716 data are representative of one of two independent experiments. ∗Significantly different from each other (p < 0.05; Mann–Whitney U test)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us